Trinity Biotech plc
NASDAQ: TRIB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- John Gillard
- Employees
- 380
- Headquarters
- Bray, Ireland
- IPO year
- 1992
- Market cap
- $3.6M
- Website
- https://www.trinitybiotech.com
Loading TRIB…
Loading profile data…Frequently asked questions about TRIB
What does Trinity Biotech plc (TRIB) do?
Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. The company's reach extends to the Americas, Africa, Asia, and Europe, catering to both clinical laboratory and point-of-care diagnostic markets. I...
Where does TRIB trade?
Trinity Biotech plc (TRIB) trades on the NASDAQ Global Select.
What sector is TRIB in?
Trinity Biotech plc (TRIB) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Trinity Biotech plc?
John Gillard is the chief executive officer of Trinity Biotech plc (TRIB).
Where is Trinity Biotech plc headquartered?
Trinity Biotech plc is headquartered in Ireland.
Does TRIB pay a dividend?
Trinity Biotech plc (TRIB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TRIB go public?
Trinity Biotech plc (TRIB) completed its initial public offering in 1992.
Is TRIB an ADR?
Yes — TRIB is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Trinity Biotech plc reporting and dividends follow the underlying issuer.